Trial Information
Randomised-controlled Trial on the Immune Response to Single-port Access Versus Conventional Laparoscopic Colorectal Surgery
Inclusion Criteria:
- large bowel disorder requiring surgical resection
- body habitus suitable for single-port access surgery
Exclusion Criteria:
- patients not capable of informed consent and/or quality of life assessment
- planned open procedure for surgical reason
- multiple previous abdominal operations
- body-mass index > 40
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Outcome Measure:
IL-6
Outcome Description:
Immune response to tissue trauma (Interleukin-6)
Outcome Time Frame:
change from baseline at 2,6,24 and 72 hours from surgery
Safety Issue:
No
Authority:
United Kingdom: National Health Service
Study ID:
SUR-089
NCT ID:
NCT01626963
Start Date:
October 2012
Completion Date:
Related Keywords:
- Colorectal Cancer
- Inflammatory Bowel Disease
- Benign Colorectal Neoplasm
- Diverticular Disease
- single-port access
- laparoscopic surgery
- surgical trauma
- Neoplasms
- Colorectal Neoplasms
- Diverticulum
- Inflammatory Bowel Diseases
- Intestinal Diseases